Danaher (DHR) Financial Analysis & Valuation | Quarter Chart
Danaher (DHR)
DHRPrice: $192.78
Fair Value: 🔒
🔒score
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectr... more
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commer... more
Description
Shares
| Market Cap | $136.44B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Diagnostics & Research |
| Country | US | CEO | Rainer Blair |
| IPO Date | 1978-12-29 | CAGR | 0.12% |
| Employees | 61,000 | Website | www.danaher.com |
| Div. Yield | 0.65% | Payout Ratio | 0.25% |
| Buy Back Yield | 1.37% | Total Yield | 2.02% |
DHR chart loading...
Fundamentals
Technicals
| Enterprise Value | $151.69B | P/E Ratio | 24.16 |
| Forward P/E | 20.93 | PEG Ratio | 3.81 |
| P/S Ratio | 5.96 | P/B Ratio | 2.79 |
| P/CF Ratio | 22.95 | P/FCF Ratio | 27.92 |
| EPS | $7.98 | EPS Growth 1Y | 0.39% |
| EPS Growth 3Y | -44.11% | EPS Growth 5Y | -18.58% |
| Revenue Growth 1Y | 4.02% | Gross Margin | 0.61% |
| Operating Margin | 0.21% | Profit Margin | 0.15% |
| ROE | 0.07% | ROA | 0.04% |
| ROCE | 0.07% | Current Ratio | 1.87 |
| Quick Ratio | 1.52 | Cash Ratio | 0.76 |
| Debt/Equity | 0.35 | Interest Coverage | 20.28 |
| Altman Z Score | 4.02 | Piotroski Score | 6 |